[1] PETRICK J L, MCGLYNN K A.The changing epidemiology of primary liver cancer[J]. Current epidemiology reports, 2019, 6(2): 104-111. [2] KHEMLINA G,IKEDA S,KURZROCK R.The biology of hepatocellular carcinoma:Implications for genomic and immune therapies[J]. Molecular cancer, 2017, 16(1): 149. [3] AMBADE A, MANDREKAR P.Oxidative stress and inflammation: Essential partners in alcoholic liver disease[J]. Hepatology international, 2012, 2012: 853175. [4] WALLACE M C,PREEN D, JEFFREY G P, et al.The evolving epidemiology of hepatocellular carcinoma: A global perspective[J]. Expert review of gastroenterology & hepatology, 2015, 9(6): 765-779. [5] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. A cancer journal for clinicians, 2018, 68(6): 394-424. [6] VALERY P C, LAVERSANNE M, CLARK P J, et al.Projections of primary liver cancer to 2030 in 30 countries worldwide[J]. Hepatology, 2017, 67(2): 600-611. [7] 尹春晖,霍诗然. 大蒜素抗癌作用及其机制研究进展[J]. 食品科学, 2009, 30(7): 270-272. [8] 张建永,杨沙,陈宽,等. 基于网络药理学的理气活血滴丸治疗心血管疾病作用机制研究[J]. 中药材, 2019(5): 1139-1145. [9] 刘志华,孙晓波. 网络药理学:中医药现代化的新机遇[J]. 药学学报, 2012, 47(6): 696-703. [10] 任俊泽,张展,李柏. 基于网络药理学探讨白头翁汤的抗肿瘤作用机制[J]. 世界临床药物, 2019, 40(4): 241-248. [11] RAPPAPORT N, FISHILEVICH S, NUDEL R, et al.Rational confederation of genes and diseases: NGS interpretation via GeneCards, MalaCards and VarElect[J]. Biomedical engineering online, 2017, 16(1): 72. [12] TANG Z, LI C, KANG B, et al.GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic acids research, 2017, 45(1): 98-102. [13] LI T, FAN J, WANG B, et al.TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer research, 2017, 77(21): 108-110. [14] PAN J H, ZHOU H, COOPER L, et al.LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers[J]. Frontiers in immunology, 2019, 10: 6. [15] 薛潇春,胡晋红. 网络药理学的研究方法与应用进展[J]. 药学实践杂志, 2015, 33(5): 401-405. [16] BAGNARDI V, ROTA M, BOTTERI E, et al.Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis[J]. British journal of cancer,2015,112(3):580-93. [17] MCGLYNN K A, LONDON W T.The global epidemiology of hepatocellular carcinoma: Present and future[J]. Clinics in liver disease, 2011, 15(2): 223-243. [18] ALZAHRANI B, ISELI T J, HEBBARD L W.Non-viral causes of liver cancer: Does obesity led inflammation play a role[J]. Cancer letters, 2014, 345(2): 223-229. [19] LIU Y, CHANG C H, MARSH G M, et al.Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis[J]. European journal of cancer, 2012, 48(14): 2125-2136. [20] NELSON N P, EASTERBROOK P J, MCMAHON B J.Epidemiology of Hepatitis B virus infection and impact of vaccination on disease[J]. Clinics in liver disease, 2016, 20(4): 607-628. [21] 刘丹璐,邓云丹,崔芬芬,等. 大蒜素对肝癌细胞血道转移的影响[J]. 亚太传统医药, 2012, 8(9): 47-48. [22] THOMAS N E, BUSAM K J, FROM L, et al.Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study[J]. Journal of clinical oncology, 2013, 31(33): 4252-4259. [23] GAO T, HAN Y, YU L, et al.CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance[J]. PLoS One, 2014, 9(3): e91771. [24] KIM D H, PARK S E, KIM M, et al.A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers[J]. Cancer, 2011, 117(17): 4080-4091. [25] SAKAMOTO Y, MAFUNE K, MORI M, et al.Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma[J]. International journal of oncology, 2000, 17(2): 237-280. [26] ICHIRO S,SUSUMU I.Protection of estrogens against the progression of chronic liver disease[J]. Hepatology research,2007,37(4):239-247. [27] OKASHA S A,YU S, DO Y, et al.Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus[J]. Toxicology, 2001, 163(1): 49-62. [28] ODOM D T,ZIZLSPERGER N,GORDON D B,et al.Control of pancreas and liver gene expression by HNF transcription factors[J]. Science, 2004, 303(5662): 1378-1381. [29] WANG S H, YEH S H, LIN W H, et al.Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α[J]. Gastroenterology, 2012, 142(4): 989-998. |